2015
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution
Walsh KM, de Smith AJ, Hansen HM, Smirnov IV, Gonseth S, Endicott AA, Xiao J, Rice T, Fu CH, McCoy LS, Lachance DH, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR, Ma X, Metayer C, Wiemels JL. A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution. Cancer Research 2015, 75: 4884-4894. PMID: 26527286, PMCID: PMC4651745, DOI: 10.1158/0008-5472.can-15-1105.Peer-Reviewed Original ResearchConceptsAcute lymphoblastic leukemiaChildhood acute lymphoblastic leukemiaLymphoblastic leukemiaCancer riskRisk allelesGeneral cancer riskPancreatic cancer riskGenome-wide association studiesCase-control populationCDKN2A variantsProtective allelesTumor growthClonal expansionChromosome 9p21.3Hispanic childrenMissense polymorphismStrong riskMissense variantsClonal evolutionRiskLeukemiaTumorsAllelic imbalanceEuropean ancestryPolymorphism
2014
A New Estimation Approach for Combining Epidemiological Data From Multiple Sources
Huang H, Ma X, Waagepetersen R, Holford TR, Wang R, Risch H, Mueller L, Guan Y. A New Estimation Approach for Combining Epidemiological Data From Multiple Sources. Journal Of The American Statistical Association 2014, 109: 11-23. PMID: 24683281, PMCID: PMC3964681, DOI: 10.1080/01621459.2013.870904.Peer-Reviewed Original ResearchEpidemiological dataPopulation-based case-control studyBehavioral Risk Factor Surveillance SystemRisk Factor Surveillance SystemConnecticut Tumor RegistryCase-control studyPancreatic cancer riskGroup of controlsGroup of casesTumor RegistryRisk factorsHealth SurveyCancer riskCertain diseasesSurveillance system